SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedMarch 2025 , the total revenue stood at Rs. 5277.80  millions.Net profit stood at Rs. 316.20  millions  compared to Rs. 281.90 millions in the corresponding previous quarter,high by 12.17%.The company reported a good operating profit of 674.60 millions compared to 576.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5277.80 5039.20 4.73 20792.10 21327.90 -2.51 20792.10 21327.90 -2.51
Other Income 45.20 75.20 -39.89 224.00 300.70 -25.51 224.00 300.70 -25.51
PBIDT 674.60 576.00 17.12 2245.70 2615.90 -14.15 2245.70 2615.90 -14.15
Interest 40.30 34.10 18.18 147.60 161.00 -8.32 147.60 161.00 -8.32
PBDT 634.30 541.90 17.05 2098.10 2454.90 -14.53 2098.10 2454.90 -14.53
Depreciation 185.30 164.20 12.85 719.20 628.50 14.43 719.20 628.50 14.43
PBT 449.00 377.70 18.88 1378.90 1826.40 -24.50 1378.90 1826.40 -24.50
TAX 132.80 95.80 38.62 368.90 472.20 -21.88 368.90 472.20 -21.88
Deferred Tax 62.20 45.60 36.40 121.50 102.10 19.00 121.50 102.10 19.00
PAT 316.20 281.90 12.17 1010.00 1354.20 -25.42 1010.00 1354.20 -25.42
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 12.78 11.43 11.82 10.80 12.27 -11.94 10.80 12.27 -11.94

IOL Chem & Pharma Share Price

91.16 5.66 (6.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×